共 68 条
InforMatrix nucleoside/nucleotide reverse transcriptase inhibitor 'backbones'
被引:2
作者:

Schreij, Gerrit
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

Janknegt, Robert
论文数: 0 引用数: 0
h-index: 0
机构:
Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands
机构:
[1] Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands
[2] Maasland Ziekenhuis, Dept Toxicol, Sittard, Netherlands
[3] Univ Hosp Maastricht, Maastricht, Netherlands
关键词:
AIDS;
combivir;
HIV;
InforMatrix;
NRTI-backbones;
truvada;
D O I:
10.1517/14656566.8.S1.S37
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
InforMatrix is an interactive decision matrix technique. This paper describes the use of InforMatrix to determine an order of merit within the various nucleoside and nucleotide reverse transcriptase inhibitors. In the order of merit, six criteria (effectiveness, safety, tolerance, convenience, usability and costs) are weighted against each other. Data necessary for this weighting process are derived from literature as well as personal practical experience. This article gives an overview of the most relevant information from clinical trials, cohort studies and databases concerning backbones consisting of two nucleoside/nucleotide reverse transcriptase inhibitors in the treatment of HIV infections, as well as a description of the interactive decision matrix technique. By using this interactive matrix technique, a rational consideration of the treatment options for backbones consisting of two nucleoside/nucleotide reverse transcriptase inhibitors becomes possible.
引用
收藏
页码:S37 / S47
页数:11
相关论文
共 68 条
[1]
Clinical pharmacokinetics of zidovudine - An update
[J].
Acosta, EP
;
Page, LM
;
Fletcher, CV
.
CLINICAL PHARMACOKINETICS,
1996, 30 (04)
:251-262

Acosta, EP
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455 UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

Page, LM
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455 UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455

Fletcher, CV
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455 UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455
[2]
Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients
[J].
Alberti, A
;
Clumeck, N
;
Collins, S
;
Gerlich, W
;
Lundgren, J
;
Palù, G
;
Reiss, P
;
Thiebaut, R
;
Weiland, O
;
Yazdanpanah, Y
;
Zeuzem, S
.
JOURNAL OF HEPATOLOGY,
2005, 42 (05)
:615-624

Alberti, A
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Clumeck, N
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Collins, S
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Gerlich, W
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Lundgren, J
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Palù, G
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Reiss, P
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Thiebaut, R
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Weiland, O
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Yazdanpanah, Y
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium

Zeuzem, S
论文数: 0 引用数: 0
h-index: 0
机构:
St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium St Pierre Univ Hosp, Div Infect Dis, B-1000 Brussels, Belgium
[3]
Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2
[J].
Amin, J
;
Moore, A
;
Carr, A
;
French, MA
;
Law, M
;
Emery, S
;
Cooper, DA
.
HIV CLINICAL TRIALS,
2003, 4 (04)
:252-261

Amin, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

Moore, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

Carr, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

French, MA
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

Law, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

Emery, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia

Cooper, DA
论文数: 0 引用数: 0
h-index: 0
机构: Univ New S Wales, Natl Ctr HIV Epidemiol & Clin REs, Sydney, NSW 2010, Australia
[4]
Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature
[J].
Ammassari, A
;
Trotta, MP
;
Murri, R
;
Castelli, F
;
Narciso, P
;
Noto, P
;
Vecchiet, J
;
D'Arminio Monforte, A
;
Wu, AW
;
Antinori, A
.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES,
2002, 31
:S123-S127

Ammassari, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

Trotta, MP
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

Murri, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

论文数: 引用数:
h-index:
机构:

Narciso, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

Noto, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

Vecchiet, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

论文数: 引用数:
h-index:
机构:

Wu, AW
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy

Antinori, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy
[5]
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
[J].
Bangsberg, DR
;
Hecht, FM
;
Charlebois, ED
;
Zolopa, AR
;
Holodniy, M
;
Sheiner, L
;
Bamberger, JD
;
Chesney, MA
;
Moss, A
.
AIDS,
2000, 14 (04)
:357-366

Bangsberg, DR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Hecht, FM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Charlebois, ED
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Zolopa, AR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Holodniy, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Sheiner, L
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Bamberger, JD
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Chesney, MA
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA

Moss, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis, Epidemiol & Prevent Intervent Ctr, San Francisco, CA 94110 USA
[6]
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort
[J].
Barret, B
;
Tardieu, M
;
Rustin, P
;
Lacroix, C
;
Chabrol, B
;
Desguerre, I
;
Dollfus, C
;
Mayaux, MJ
;
Blanche, S
.
AIDS,
2003, 17 (12)
:1769-1785

Barret, B
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Tardieu, M
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Rustin, P
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Lacroix, C
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Chabrol, B
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Desguerre, I
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Dollfus, C
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Mayaux, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France

Blanche, S
论文数: 0 引用数: 0
h-index: 0
机构: Hop Necker Enfants Malad AP HP, Unite Immunol Hematol Pediat, F-75743 Paris 15, France
[7]
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults
[J].
Bartlett, John A.
;
Fath, Michael J.
;
DeMasi, Ralph
;
Hermes, Ashwaq
;
Quinn, Joseph
;
Mondou, Elsa
;
Rousseau, Franck
.
AIDS,
2006, 20 (16)
:2051-2064

Bartlett, John A.
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

Fath, Michael J.
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

DeMasi, Ralph
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

Hermes, Ashwaq
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

Quinn, Joseph
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

Mondou, Elsa
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA

Rousseau, Franck
论文数: 0 引用数: 0
h-index: 0
机构: Abbott Labs, Abbott Pk, IL 60064 USA
[8]
InforMatrix as an alternative tool in rational and transparent drug-decision making
[J].
Brenninkmeijer, Rob
;
Mairs, Jill
;
Timoney, Mark
;
Scott, Mike
;
McElnay, James
;
Janknegt, Robert
.
EXPERT OPINION ON PHARMACOTHERAPY,
2007, 8
:S31-S36

Brenninkmeijer, Rob
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

Mairs, Jill
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

Timoney, Mark
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

Scott, Mike
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

McElnay, James
论文数: 0 引用数: 0
h-index: 0
机构: Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

Janknegt, Robert
论文数: 0 引用数: 0
h-index: 0
机构:
Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands
[9]
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study
[J].
Carr, A
;
Chuah, J
;
Hudson, J
;
French, M
;
Hoy, J
;
Law, M
;
Sayer, D
;
Emery, S
;
Cooper, DA
.
AIDS,
2000, 14 (09)
:1171-1180

Carr, A
论文数: 0 引用数: 0
h-index: 0
机构:
St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Chuah, J
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Hudson, J
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

French, M
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Hoy, J
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Law, M
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Sayer, D
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Emery, S
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

Cooper, DA
论文数: 0 引用数: 0
h-index: 0
机构: St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia
[10]
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients
[J].
Carr, A
;
Vella, S
;
deJong, MD
;
Sorice, F
;
Imrie, A
;
Boucher, CA
;
Cooper, DA
.
AIDS,
1996, 10 (06)
:635-641

Carr, A
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

Vella, S
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

deJong, MD
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

Sorice, F
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

Imrie, A
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

Boucher, CA
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA

Cooper, DA
论文数: 0 引用数: 0
h-index: 0
机构: ST VINCENTS HOSP,CTR IMMUNOL,SYDNEY,NSW 2010,AUSTRALIA